One-Year Outcomes of 1 Dose versus 3 Loading Doses Followed by Pro Re Nata Regimen Using Ranibizumab for Neovascular Age-Related Macular Degeneration: The ARTIS Trial

Purpose. To compare the functional and anatomical outcomes of one dose and three loading doses followed by the pro re nata (PRN) regimen in Chinese neovascular age-related macular degeneration (nvAMD) (including polypoidal choroidal vasculopathy (PCV)) patients. Methods. In this multicenter, prospec...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Fenghua, Yuan, Yuanzhi, Wang, Ling, Ye, Xiaofeng, Zhao, Jingke, Shen, Mengxi, Zhang, Qi, Xu, Ding, Qin, Guoyou, Zhang, Wei, Yuan, Fei, Chang, Qing, Zhao, Peiquan, Wang, Fang, Sun, Xiaodong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2019
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6811781/
https://www.ncbi.nlm.nih.gov/pubmed/31687203
http://dx.doi.org/10.1155/2019/7530458

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6811781/
https://www.ncbi.nlm.nih.gov/pubmed/31687203
http://dx.doi.org/10.1155/2019/7530458

Ejemplares similares